Extended Data Fig. 6: T785-ISACs are efficacious in the HCC1954 and JIMT-1 tumor models. | Nature Cancer

Extended Data Fig. 6: T785-ISACs are efficacious in the HCC1954 and JIMT-1 tumor models.

From: Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunity

Extended Data Fig. 6: T785-ISACs are efficacious in the HCC1954 and JIMT-1 tumor models.

a, In vitro HER2 expression of the HCC1954 tumor cell line assessed by flow cytometry with PE-labeled anti-HER2 antibody (clone 24D2) (blue) or the isotype control (red). b-e, Spider plots visualizing tumor growth kinetics and survival for individual animals which are shown as mean tumor volume in Fig. 4. f, In vitro HER2 expression of the JIMT-1 tumor cell line assessed by flow cytometry with PE-labeled anti-HER2 antibody (clone 24D2) (blue) or the isotype control (red). g-h, Spider plots visualizing tumor growth kinetics and survival for individual animals which are shown as mean tumor volume in Fig. 4.

Source data

Back to article page